Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of Shareholders
Ginkgo Bioworks (NYSE: DNA) announced a presentation and Q&A session on March 28, 2022, to review business performance for the fourth quarter and full year ended December 31, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) announced a presentation and Q&A session on March 28, 2022, to review business performance for the fourth quarter and full year ended December 31, 2021. The session will begin at 4:30 p.m. ET, with details available on their investor relations site. Additionally, the company will hold its annual shareholder meeting on June 10, 2022, allowing participation through a virtual platform for shareholders of record as of April 14, 2022.
Positive
- Scheduled presentation for Q4 and full-year 2021 business performance.
- Annual shareholder meeting facilitates direct engagement.
Negative
- None.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was -0.67%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Presentation and Q&A session scheduled for post-market on Monday, March 28, 2022
BOSTON, March 17, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the fourth quarter and full year ended December 31, 2021, on Monday, March 28, 2022, beginning at 4:30 p.m. ET.
The presentation details and webcast registration link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
Ginkgo also announced today that the 2022 Annual Meeting of Shareholders will be held Friday, June 10, 2022, at 2:00 p.m. ET. Shareholders may participate in the virtual meeting online, vote their shares electronically and submit live questions by following the instructions in their proxy materials. Shareholders of record as of April 14, 2022 will be entitled to notice of, and to attend and vote at, the Annual Meeting.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2021-results-presentation-and-date-for-annual-meeting-of-shareholders-301505006.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.